日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The polyamine inhibitor SAM486A increases the efficacy of adagrasib in non-small cell lung cancer cells harboring KRAS(G12C) mutation

多胺抑制剂SAM486A可增强阿达格拉西布对携带KRAS(G12C)突变的非小细胞肺癌细胞的疗效

Martin-Martin, Antonia; Chipón, Carina; Guzman-Kunstmann, Constanza; Guzman-Kunstmann, Sergio; Buelvas, Neudo; Henríquez, Claudio; Vidal, Francisca; Villarroel-Espindola, Franz; Hinz, Trista K; Heasley, Lynn E; López-Muñoz, Rodrigo A

Orthotopically Implanted Murine Lung Adenocarcinoma Cell Lines for Preclinical Investigations

用于临床前研究的原位移植小鼠肺腺癌细胞系

Kalyanaraman, Karshana J; Corey, Zachary; Navarro, Andre; Heasley, Lynn E; Nemenoff, Raphael A

Novel PLEC-EML4-ALK Double Fusion Underlying Crizotinib Resistance in a Metastatic Inflammatory Myofibroblastic Tumor: A Case Report

转移性炎性肌纤维母细胞瘤中克唑替尼耐药的新型PLEC-EML4-ALK双融合基因:病例报告

Maleddu, Alessandra; Hinz, Trista K; Black, Margaret A; Aisner, Dara L; Marshall, Carrie B; Elias, Anthony D; Wilky, Breelyn A; Heasley, Lynn E; Davies, Kurtis D

Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinoma

小鼠RET+肺腺癌获得性TKI耐药及有效联合治疗策略模型

Hinz, Trista K; Le, Anh T; Doan, Tristan; Ast, Abby; Jaramillo, Sophia; Haines, Samantha; Navarro, Andre; Patil, Tejas; Nemenoff, Raphael A; Heasley, Lynn E

Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib

利用FGFR1 mRNA和基因拷贝数对肺癌病例进行预筛选,以进行帕纳替尼治疗

Ng, Terry L; Yu, Hui; Smith, Derek E; Boyle, Theresa A; York, Emily R; Leedy, Scott; Gao, Dexiang; Aisner, Dara L; Van Bokhoven, Adrie; Heasley, Lynn E; Hirsch, Fred R; Camidge, D Ross

Subcellular Localization and Activity of the Mitogen-Activated Protein Kinase Kinase 7 (MKK7) γ Isoform are Regulated through Binding to the Phosphatase Calcineurin

丝裂原活化蛋白激酶激酶7 (MKK7) γ亚型的亚细胞定位和活性受磷酸酶钙调磷酸酶的结合调控。

Gibson, Emily S; Woolfrey, Kevin M; Li, Huiming; Hogan, Patrick G; Nemenoff, Raphael A; Heasley, Lynn E; Dell'Acqua, Mark L

Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities

靶向受体酪氨酸激酶抑制剂引发的癌细胞快速重编程机制及其固有的治疗脆弱性

Kleczko, Emily K; Heasley, Lynn E

A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines

miRNA 谱预测肺癌细胞系对 FGFR 抑制剂的敏感性

Ren, Shengxiang; Rivard, Christopher J; Yu, Hui; Genova, Carlo; Rozenboom, Leslie; Gao, Dexiang; Hinz, Trista K; Rikke, Brad A; Wynes, Murry W; Caldwell, Charles; Agustoni, Francesco; Kenichi Suda; Jiang, Tao; Zhou, Caicun; Heasley, Lynn E; Hirsch, Fred R

The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade

肿瘤微环境调节小鼠肺肿瘤对PD-1/PD-L1抗体阻断的敏感性

Li, Howard Y; McSharry, Maria; Bullock, Bonnie; Nguyen, Teresa T; Kwak, Jeff; Poczobutt, Joanna M; Sippel, Trisha R; Heasley, Lynn E; Weiser-Evans, Mary C; Clambey, Eric T; Nemenoff, Raphael A

FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.

在所有肺癌组织学类型中,FGFR1 mRNA 和蛋白质表达,而不是基因拷贝数,可以预测 FGFR TKI 的敏感性

Wynes Murry W, Hinz Trista K, Gao Dexiang, Martini Michael, Marek Lindsay A, Ware Kathryn E, Edwards Michael G, Böhm Diana, Perner Sven, Helfrich Barbara A, Dziadziuszko Rafal, Jassem Jacek, Wojtylak Szymon, Sejda Aleksandra, Gozgit Joseph M, Bunn Paul A Jr, Camidge D Ross, Tan Aik-Choon, Hirsch Fred R, Heasley Lynn E